Sun Pharmaceutical Industries Limited has informed the Exchange regarding Appointment of Independent Director
SUNPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sun Pharma's Board has approved the appointment of Ms. Satyavati Berera as an Independent Director for a term of 5 years, subject to shareholder approval via postal ballot. Ms. Berera is a former Chief Operating Officer of PwC India with over 40 years of experience in Assurance, Consulting, and Governance Risk and Compliance services. She brings expertise in Finance, Operations, Human Capital, Technology, and Regulatory compliance. The company states she is not related to any Director, Key Managerial Personnel, or promoter. The appointment is intended to reinforce board independence, governance effectiveness, and oversight capabilities while maintaining compliance with Companies Act 2013 and SEBI LODR requirements.
This appointment strengthens Sun Pharma's board governance and independence credentials. The addition of an experienced professional with extensive finance and compliance background is positive for shareholder confidence, though the appointment remains pending shareholder approval.